Welcome to The Visible Embryo



Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform

The World Health Organization (WHO) has created a new Web site to help researchers, doctors and
patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.


Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007

Home | Pregnancy Timeline | News Alerts |News Archive Feb 13, 2014


An intron is any sequence within a gene removed by RNA splicing.
Intron sequences joined together in the final RNA, after splicing, are called exons.

Image credit: Wikipedia.org

WHO Child Growth Charts




Found gene defect causes developmental errors

Melbourne researchers have made a major step in understanding changes in the cellular process called minor class splicing. The defect may cause a severe developmental disease known as Taybi-Linder syndrome.

Using zebrafish, a popular laboratory model for studying development, researchers have discovered that the protein Rnpc3 is critical to the growth of many organs. Rnpc3 regulates protein production through a process called minor class messenger RNA splicing.

Messenger RNA is a molecule required to convert gene blueprints coded in DNA into proteins. Using a 'cut and paste' process, RNA cuts unwanted sequences — called introns — out of messenger RNA, and pastes the remaining pieces back together again.Without splicing these unwanted sequences, proteins cannot be made correctly from genes.

Joan Heath, Ludwig Member and Associate Professor at the Walter and Eliza Hall Institute, and Dr Sebastian Markmiller, University of California, San Diego, found that the protein Rnpc3 is required for the rapid growth of organs, including the intestine, liver, pancreas and eye, during zebrafish development. Their findings are published in the journal Proceedings of the National Academy of Sciences.

Associate Professor Heath said the discovery was important because it helped shed light on how defects in minor class splicing cause a severe human developmental disorder known as Taybi-Linder syndrome.

"Altogether there are about 200,000 introns in the genome [all the genetic material in one individual]. Most introns are removed through a process known as major class splicing.

"Minor class splicing is more rare and removes only a few hundred introns. Why minor class splicing exists at all, and how important it is, has eluded geneticists for more than two decades.
We have now discovered that minor class splicing is critical to the expression of genes that regulate gene expression.

"Defects in minor class splicing effects which genes are switched on — particularly critical in development when rapid changes in gene expression and protein production are required.

"In the long-run, we anticipate our research will show that minor class splicing contributes to other diseases currently not fully understood,"

Joan Heath, Associate Professor and Ludwig Member, Walter and Eliza Hall Institute

The accurate removal of introns by pre-mRNA splicing is a critical step in proper gene expression. Most eukaryotic genomes, from plant to human, contain a tiny subset of “minor class” introns with unique sequence elements that require their own splicing machinery. The significance of this second splicing pathway has intrigued RNA biologists for two decades, but its biological relevance was recently underscored when defects in the process were firmly linked to human disease. Here, we use a novel zebrafish mutant with defective minor class splicing to investigate how this pathway shapes the transcriptome during vertebrate development. We link its pleiotropic phenotype to widespread changes in gene expression that disrupt essential cellular pathways, including mRNA processing.

Minor class or U12-type splicing is a highly conserved process required to remove a minute fraction of introns from human pre-mRNAs. Defects in this splicing pathway have recently been linked to human disease, including a severe developmental disorder encompassing brain and skeletal abnormalities known as Taybi-Linder syndrome or microcephalic osteodysplastic primordial dwarfism 1, and a hereditary intestinal polyposis condition, Peutz-Jeghers syndrome. Although a key mechanism for regulating gene expression, the impact of impaired U12-type splicing on the transcriptome is unknown. Here, we describe a unique zebrafish mutant, caliban (clbn), with arrested development of the digestive organs caused by an ethylnitrosourea-induced recessive lethal point mutation in the rnpc3 [RNA-binding region (RNP1, RRM) containing 3] gene. rnpc3 encodes the zebrafish ortholog of human RNPC3, also known as the U11/U12 di-snRNP 65-kDa protein, a unique component of the U12-type spliceosome. The biochemical impact of the mutation in clbn is the formation of aberrant U11- and U12-containing small nuclear ribonucleoproteins that impair the efficiency of U12-type splicing. Using RNA sequencing and microarrays, we show that multiple genes involved in various steps of mRNA processing, including transcription, splicing, and nuclear export are disrupted in clbn, either through intron retention or differential gene expression. Thus, clbn provides a useful and specific model of aberrant U12-type splicing in vivo. Analysis of its transcriptome reveals efficient mRNA processing as a critical process for the growth and proliferation of cells during vertebrate development.

1Present address: Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla CA 92093.

2N.C. and R.M.L. contributed equally to this work.

3Present address: QIMR Berghofer Medical Research Institute, Genomic Biology Laboratory, Herston, QLD 4006, Australia.

4Present address: Division of Biology, University of California, San Diego, La Jolla, CA 92093.

5Present address: Institute of Medical Biology, Agency for Science, Technology and Research (A-STAR), Singapore 138648.

6Present address: The Danish Stem Cell Centre, University of Copenhagen, 2200 Copenhagen, Denmark.

7Present address: Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, D-61231 Bad Nauheim, Germany.

8To whom correspondance should be addressed. E-mail: joan.heath@wehi.edu.au.
Author contributions: S.M., R.M.L., and J.K.H. designed research; S.M., R.M.L., K.D., M.-C.K., Y.B., A.J.T., A.Y.N., S.J.W., and H.V. performed research; N.C., H.V., E.A.O., H.A.F., S.M.G., and D.Y.R.S. contributed new reagents/analytic tools; S.M., N.C., R.M.L., K.D., M.-C.K., Y.B., A.J.T., A.Y.N., S.J.W., G.J.L., and J.K.H. analyzed data; and S.M. and J.K.H. wrote the paper.

The authors declare no conflict of interest.

*This Direct Submission article had a prearranged editor.

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE53935).

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1305536111/-/DCSupplemental.

Freely available online through the PNAS open access option.

The research was supported by the Australian National Health and Medical Research Council, the Boehringer Ingelheim Foundation, Ludwig Cancer Research and the Victorian Government.